New Spin-off Company founded by FORTH for the production of reflection-free glass that improves the quality of consumer electronics displays
A new spin-off company under the name “Biomimetic” was created leveraging patented technology developed at the Institute of Electronic Structure and Laser (IESL, www.iesl.forth.gr) of the Foundation for Research and Technology-Hellas (www.forth.gr). The company was founded by the Research Director Dr. Emmanuel Stratakis, together with FORTH research personnel Dr. Evangelos Skoulas, Mr. Andreas Lemonis, Mr. Antonis Papadopoulos and Mr. Alexandros Mimidis, as co-founders. The company raised 900.000€ seed funding by Big Pi Ventures (https://bigpi.vc/), one of the funds of EquiFund supported by the European Investment Fund (EIF). It is the second spin-off company of IESL that is financed by Big Pi within the last six months.
Novel method for COVID-19 diagnosis developed at FORTH receives funding for immediate market release
Biosensors lab of FORTH(http://biosensorslab.biology.uoc.gr/) has developed a novel molecular diagnostic method for the detection of nucleic acids at the point-of-care. The method exploits a newly designed portable 3D-printed device and a smartphone to perform isothermal amplification and real-time quantitative colorimetric detection of the target analyte. The simplicity of the methodology, rapid analysis time (<30 min) and affordable cost make it ideal for non-trained users at the point-of-need and in both the developed and resource limited countries. Clinical validation of the device with patients’ samples, for infectious diseases (COVID-19) and cancer-mutations (BRAF V600E) detection, demonstrated excellent performance compared to standard methods.
FORTH collaborating researcher’s major contribution to an important scientific publication in a leading medical journal, about a targeted treatment for Tumor-Induced Osteomalacia (TIO).
Dr Georgios Z. Papadakis, collaborating researcher of the Institute of Computer Science (ICS) of the Foundation for Research and Technology – Hellas (FORTH), had a major contribution on a study published on September 10th 2020, in the New England Journal of Medicine (NEJM), in collaboration with scientists from the National Institutes of Health (NIH) in Bethesda, Maryland, USA.
IMBB Researchers and Scientists from the University of Padova uncover a novel pathogenesis mechanism for Autosomal Dominant Optic Atrophy, an incurable, visual loss disorder.
The findings of the study, published yesterday in the premier international scientific journal Nature Communications, reveal a novel molecular mechanism underlying the detrimental effects of uncontrolled mitophagy on neuronal survival that contributes to the development and progression of Autosomal Dominant Optic Atrophy (ADOA).
A European “Key Innovator” Distinction to an IESL project
The European project NANOPOLY (FETOPEN 2019 – 2022) that runs in the Institute of Electronic Structure and Laser (IESL) of the Foundation for Research and Technology Hellas (FORTH) has been awarded a “Key innovator” distinction by the European “Innovation Radar” https://www.innoradar.eu/resultbykeyword/nanopoly)
Greece among the top European countries in Supercomputer technologies
Supercomputers and large Datacenters constitute basic infrastructure of strategic importance in modern society. Among the many sectors that they support, it suffices to mention the search for drugs against covid-19, and the fact that applications like gov.gr and global-scale teleconferencing, teleworking, and on-line education all run on large Datacenters. Recognizing the strategic importance of these High Performance Computing (HPC) technologies, the European Union has been funding related research, and has recently created the EuroHPC Joint Undertaking (JU) with a 1 billion Euro budget.
Neuroimplants to treat spinal cord injuries
A pioneering research study by researchers at the Institute of Molecular Biology & Biotechnology of FORTH and the University of Crete suggests the development of neuroimplants for the regeneration of nerve tissue in cases of spinal cord injury. The materials and cells used are non-toxic for humans, and approved from FDA for their immediate translation in humans.
FORTH coordinates the National Precision Medicine Network for Neurodegenerative Diseases
A new emblematic initiative, the National Network for Neurodegenerative Disease Research towards Precision Medicine, commences its operation in Greece. This flagship initiative positions Greece at the forefront of neurodegeneration and ageing research, with initial funding of € 2.2 million, over a two-year implementation period, provided by the Ministry of Development and Investments, through the General Secretariat for Research and Technology. The pioneering Network comprises leading National Research Centers and Universities, and is coordinated by the Foundation for Research and Technology - Hellas (FORTH), with the National and Kapodistrian University of Athens (NKUA) as co-coordinator.
Population genomics insights into the recent evolution of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic, caused by SARS-CoV-2, still grows rapidly. A recent study published as a preprint manuscript in BioRxiv by researchers from FORTH-ICS, FORTH-IMBB and the University of Western Attica, provides new insights into the evolution of SARS-CoV-2 virus.
FORTH’s Digital Innovation Initiative against COVID-19
The Centre for eHealth Applications and Services (CeHA), of the Institute of Computer Science, Foundation for Research and Technology – Hellas (FORTH-ICS), responded to the "Rapid Implementation of Mature Digi-Tech Solutions" invitation of the Hellenic Ministry of Digital Governance for utilization or repurposing already existing infrastructure and ready to use solutions for direct implementation and results.
Page:1 .... 123456789 | < Prev Next >